CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...